Resistance-associated substitution and ledipasvir/sofosbuvir therapy in Mongolian chronic hepatitis C patients
Hsu, Shih-Jer, Enkhzaya, Sukhee, Lin, You-Yu, Tseng, Tai-Chung, Khosbayar, Tulgaa, Tsai, Cheng-Hsueh, Wang, Tzu-San, Enkhtuya, Damba, Ivshinkhorol, Dogsom, Naranzul, Nyamsuren, Jargalsaikhan, Badarch, Amarsanaa, Jazag, Baatarkhuu, Oidov, Kao, Jia-Horng
Published in Journal of the Formosan Medical Association (01.03.2020)
Published in Journal of the Formosan Medical Association (01.03.2020)
Get full text
Journal Article
Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway
Liu, Wei-Liang, Yang, Hung-Chih, Hsu, Ching-Sheng, Wang, Chih-Chiang, Wang, Tzu-San, Kao, Jia-Horng, Chen, Ding-Shinn
Published in Proceedings of the National Academy of Sciences - PNAS (20.12.2016)
Published in Proceedings of the National Academy of Sciences - PNAS (20.12.2016)
Get full text
Journal Article
Pegylated IFN-a suppresses hepatitis C virus by promoting the DAPK-mTOR pathway
Liu, Wei-Liang, Yang, Hung-Chih, Hsu, Ching-Sheng, Wang, Chih-Chiang, Wang, Tzu-San, Kao, Jia-Horng, Chen, Ding-Shinn
Published in Proceedings of the National Academy of Sciences - PNAS (20.12.2016)
Get full text
Published in Proceedings of the National Academy of Sciences - PNAS (20.12.2016)
Journal Article